IAS–USA Virtual Update on HIV: Antiretroviral Therapy, New ART Drugs and Strategies, and the Intersection of COVID-19 and HIV
IMPORTANT: If you registered for the course before Wednesday, July 29, an email from IAS-USA Support (a no-reply Zoom address) with your personal link to access the virtual course was sent to you today at 2:00 PM Central Time (12:00 PM PT, 1:00 PM MT, 3:00 PM ET). You will also receive an email reminder (more…)
Current Status of COVID-19 Treatment and Vaccine Research
Program Description The COVID-19 pandemic has created an urgent need for reliable scientific information. Our understanding of SARS-CoV-2 and COVID-19 disease changes almost daily. Unfortunately, there are also misunderstandings, miscommunications, and controversies. In response, the IAS−USA has created a program that will bring together leading experts to discuss the latest science regarding COVID-19 and what (more…)
RWCC 2020 Breakout-Sessions
Meet-the-Expert Breakout Session registration is now open for the virtual 2020 Ryan White HIV/AIDS Program CLINICAL CONFERENCE for registered attendees. To register for your sessions, please click the link below and follow the prompts to register for a session for each day. There will be 6 sessions offered from August 9 to 11. There (more…)
The 2020 Ryan White HIV/AIDS Program CLINICAL CONFERENCE
Pacific Time Mountain Time Central Time Eastern Time Sunday, August 9 7:00 AM – 12:00 PM 8:00 AM – 1:00 PM 9:00 AM – 2:00 PM 10:00 AM – 3:00 PM Monday, August 10 7:00 AM – 11:30 PM 8:00 AM – 12:30 PM 9:00 AM – 1:30 PM 10:00 AM – 2:30 PM (more…)
Management and Prevention of HIV Infection Among Transgender Adults
Overview Assessment of Needs The IAS–USA offers this state-of-the-art activity on the evolving challenges of managing HIV disease as part of a nationwide continuing medical education (CME) effort for physicians. Transgender and gender diverse people have disparate rates of HIV infection compared with cisgender populations due to a combination of structural, individual, interpersonal, biologic, and (more…)
Continued Discussion on COVID-19 Epidemiology and Transmission
Program Description The IAS–USA COVID-19 Dialogues bring together leading experts to discuss what the data and research are telling us about the basic science, public health, and clinical aspects of the disease and the consequences of the pandemic. The Dialogues are intended for healthcare clinicians and researchers, but anyone interested is welcome to join. This (more…)
Liver Transplant Among People With HIV
Overview Assessment of Needs This webinar will discuss the evolving landscape of end-stage liver disease among people with HIV (PWH) and indications for liver transplantation. It will review the improved outcomes of liver transplantation in this population in the recent era, as well as barriers to access and potential challenges after transplant. Learning Objectives Upon (more…)
(Part 1 of 4) Chronic Pain in People With HIV: An Evidence-Based, Practical Approach
Overview Assessment of Needs Chronic pain is common in people with HIV (PWH), and has been associated with adverse HIV-related outcomes. This talk will provide a brief summary of the evidence base behind the epidemiology, pathophysiology, and treatment of chronic pain in PWH, and will then focus on a practical approach to management. Management approaches (more…)
New Strategies and Challenges of PrEP in the COVID-19 Era
Program Description The Dialogue series is intended for healthcare clinicians and researchers, including infectious disease and HIV specialists. In this Dialogue, Dr Raphael J. Landovitz of the University of California Los Angeles and Dr E. Turner Overton of the University of Alabama at Birmingham will discuss new findings and challenges regarding HIV preexposure prophylaxis (PrEP), (more…)
HIV and COVID-19 Interactions and Parallels in Advocacy
Program Description The IAS–USA COVID-19 Dialogues bring together leading experts to discuss what the data and research are telling us about the basic science, public health, and clinical aspects of the disease and the consequences of the pandemic. The Dialogue series is intended for healthcare clinicians and researchers, including infectious disease and HIV specialists. This (more…)